Výsledky vyhledávání - "Chur Woo You"

Akademický článek

Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea

Autor: Byung Suk Moon, Jun Seok Choi, Chur Woo You

Publikováno v: Korean Journal of Pediatrics, Vol 56, Iss 7, Pp 291-297 (2013)

PurposeThe aim of this study was to investigate prophylactic treatment effects in Korean patients with severe hemophilia A.MethodsA prospective study of 32 severe hemophilia A patients was conducted with the approval of the Institutional Review Board

Externí odkaz: https://doaj.org/article/b823beda0695487e9355300b24a88435

Zobrazit plný text záznamu

Akademický článek

A pediatric case of idiopathic Harlequin syndrome

Autor: Ju Young Kim, Moon Souk Lee, Seung Yeon Kim, Hyun Jung Kim, Soo Jin Lee, Chur Woo You, Jon Soo Kim, Ju Hyung Kang

Publikováno v: Korean Journal of Pediatrics, Vol 59, Iss Suppl 1, Pp S125-S128 (2016)

Harlequin syndrome, which is a rare disorder caused by dysfunction of the autonomic system, manifests as asymmetric facial flushing and sweating in response to heat, exercise, or emotional factors. The syndrome may be primary (idiopathic) with a beni

Externí odkaz: https://doaj.org/article/8678301c8cba430caa9946401935cd7f

Zobrazit plný text záznamu

Akademický článek

S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS

Autor: Gili Kenet, Beatrice Nolan, Bulent Zulfikar, Bulent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N. Bag, Azizan Sharif, Flora Peyvandi, Guy Young, Claude Negrier, Christian Sussebach, Fadi Shammas, Shauna Andersson, Baisong Mei, Kaan Kavakli

Publikováno v: HemaSphere, Vol 7, p e643526e (2023)

Externí odkaz: https://doaj.org/article/2a45dff57f9c4ff2bedf75d75d9983b0

Zobrazit plný text záznamu

Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial

Autor: Alok Srivastava, Savita Rangarajan, Kaan Kavakli, Robert Klamroth, Gili Kenet, Liane Khoo, Chur-Woo You, Weiqun Xu, Niel Malan, Laurent Frenzel, Catherine N Bagot, Oleksandra Stasyshyn, Chia-Yau Chang, Stacey Poloskey, Zhiying Qiu, Shauna Andersson, Baisong Mei, Steven W Pipe

Publikováno v: The Lancet Haematology. 10:e322-e332

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::69e0609c06dd026ce31292efb0be346b
https://doi.org/10.1016/s2352-3026(23)00037-6

Zobrazit plný text záznamu

Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial

Autor: Guy Young, Alok Srivastava, Kaan Kavakli, Cecil Ross, Jameela Sathar, Chur-Woo You, Huyen Tran, Jing Sun, Runhui Wu, Stacey Poloskey, Zhiying Qiu, Salim Kichou, Shauna Andersson, Baisong Mei, Savita Rangarajan

Publikováno v: The Lancet. 401:1427-1437

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::696e5ba6c9ef0e57ab61a683475344e1
https://doi.org/10.1016/s0140-6736(23)00284-2

Zobrazit plný text záznamu

Active Lifestyle in Patients with Hemophilia A or B with Inhibitors on Once-Daily Subcutaneous Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Autor: Laura Villarreal Martinez, Katarina Cepo, Jannie Laursen, Jan Odgaard-Jensen, Chur-Woo You, Jerzy Windyga

Publikováno v: Blood. 140:5634-5636

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa9031a122f786b23e5f5f54373737f6
https://doi.org/10.1182/blood-2022-167076

Zobrazit plný text záznamu

Clinical Analysis of Hospitalized Patients with Hemophilia A: Single-hemophilia Treatment Center Experience in Korea over 10 years

Autor: Chur Woo You, Se Jin Park, Ju Young Kim

Publikováno v: Blood research

Background There is lack of data on admitted hemophilia patients in Korea. For this reason, this study was intended to analyze the hospitalization data of hemophilia patients in a regional Hemophilia Treatment Center (HTC) for the first time in Korea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91ae4f00e9be91516e1a7e586ce0d65
https://doi.org/10.5045/br.2021.2020289

Zobrazit plný text záznamu

Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients

Autor: Sang Kyu Park, Werner Engl, Hee Jo Baek, Srilatha Tangada, Ho-Jin Shin, Chur Woo You, Young Shil Park

Publikováno v: Blood research

Background The efficacy and safety of extended half-life, full-length, pegylated recombinant factor VIII rurioctocog alfa pegol [BAX 855, ADYNOVATE (USA)/ADYNOVI (Europe); Baxalta US Inc., a Takeda company, Lexington, MA, USA] was investigated in pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c34293fb4286fbb5d0db22637f081d
https://doi.org/10.5045/br.2019.54.3.198

Zobrazit plný text záznamu

Long-term safety and efficacy of N8-GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2

Autor: Faraizah Abdul Karim, Milan S. Geybels, Andrea Landorph, Nicola Curry, László Nemes, Paul Giangrande, Chur Woo You

Publikováno v: Journal of Thrombosis and Haemostasis

Background N8-GP (turoctocog alfa pegol; Esperoct® , Novo Nordisk A/S, Bagsvaerd, Denmark) is a glycoPEGylated human recombinant factor VIII with a half-life of ~1.6-fold of standard FVIII products. pathfinder2 (NCT01480180) was a multi-national, op

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070b1525f24cabd47f3ad6338bb460fb
https://pubmed.ncbi.nlm.nih.gov/32544297

Zobrazit plný text záznamu

Akademický článek

Heterogeneous lengths of copy number mutations in human coagulopathy revealed by genome-wide high-density SNP array

Autor: Hee-Jin Kim, Duk-Kyung Kim, Ki-Young Yoo, Chur-Woo You, Jong-Ha Yoo, Ki-O Lee, In-Ae Park, Hae-Sun Choung, Hee-Jung Kim, Min-Jung Song, Sun-Hee Kim

Publikováno v: Haematologica, Vol 97, Iss 2 (2012)

Background The recent advent of genome-wide molecular platforms has facilitated our understanding of the human genome and disease, particularly copy number aberrations. We performed genome-wide single nucleotide polymorphism-array in hereditary coagu

Externí odkaz: https://doaj.org/article/9711dbfa605c412b9f7475abe04c831b

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání